• Return to Headlines

After Yesterday's Decline of 2.65%, Biomarin Pharmac Offers Investors Better Value

By Shiri Gupta

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $88.45 to a high of $91.20. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $88.60 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

In the past 52 weeks, shares of Biomarin Pharmac have traded between a low of $73.45 and a high of $102.49 and are now at $88.71, which is 21% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has slid 1.2%.

SmarTrend is tracking the current trend status for Biomarin Pharmac and will alert subscribers who have BMRN in their portfolio or watchlist when shares have changed trend direction.

Keywords: rebounders biomarin pharmac

Ticker(s): BMRN